Expansion Brings Full Scale Production Capability

Since installation of bulk production capability for its colloidal gold nanoparticle products, Innova Biosciences, a specialist provider of bioconjugation products and services can now offer support for any scale of operation, including the largest players in the diagnostics field.

The Company has also taken a further 2500 sq ft of office space at the South Cambridge Business Park, which will be occupied by its sales and marketing team.

Dr Nick Gee, CEO of Innova Biosciences, commented: “Innova is committed to supporting all customers with the same high level of service and consistency in quality, from academic researchers through to bulk manufacturing scientists.”

Gold nanoparticles are used in many applications such as lateral flow point-of-care assays, microscopy, flow cytometry, Raman spectroscopy and dynamic light scattering.